Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today announced the publication of the first clinical study evaluating its SeptAligntm ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which ...

NEW YORK, DE, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- The sleep apnea implants market generated USD 451.6 million ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as ...

Background Many studies show a link between forced expiratory volume in 1 s (FEV 1) and survival in the general population and this has been interpreted as a link between airway obstruction and ...

Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of ...

The new funding will support MOS118 through its Phase II development while expanding Mosanna's product pipeline.